Factsheet: Information About the ACAM2000 Vaccine for Preventing Mpox
Factsheet: Information About the ACAM2000 Vaccine for Preventing Mpox
Date posted:
September 15, 2022
Last reviewed:
March 13, 2024
Centers for Disease Control and Prevention (CDC)
Factsheet provides interim guidance to healthcare providers on the use of the ACAM2000 vaccine for the prevention of mpox. CDC recommends that vaccination with ACAM2000 can be considered for people aged 1 year and older who have been determined to be at high risk for infection. The factsheet provides information about the vaccine schedule, duration of immunity, quality of the evidence of effectiveness, and vaccine administration. The factsheet is available at: ACAM2000 Vaccine | CDC.
Toolkit: Resources to Increase Parents' Confidence in the COVID-19 Vaccine (English, Spanish)
Matching terms:
Branded Multiple Races/Ethnicities Safety Effectiveness
Report: The U.S. COVID-19 Vaccination Program at One Year
Matching terms:
COVID-19 Branded Document (Text) Multiple Races/Ethnicities
Toolkit: Advocacy Training for Community Health Workers
Matching terms:
Branded
Social Media: Graphic Emphasizes that Vaccines Keep Your Children Safe From COVID-19
Matching terms:
Social Media COVID-19 Unbranded Graphic / Image Effectiveness
Report: Protecting New Yorkers Through Immunization: State Department of Health Updates New Yorkers On Polio In New York State
Matching terms:
Branded Website Safety Effectiveness Eligibility
Social Media: Graphic on Encountering Online Misinformation (English, Spanish)
Matching terms:
COVID-19